Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin in Rectocele Repair
NCT06804993Phase 4Active, not recruiting
- Sponsor
- Mansoura University
- Start
- Jul 2021
- Primary completion
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in obstructed defecation syndrome (ODS), Rectocele, sponsored by Mansoura University. Started Jul 2021; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
obstructed defecation syndrome (ODS)Rectocele
Beyond the preview
Go deeper on NCT06804993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06804993.